However, in a tumor both CCL3 and CCL4 may be cleaved by cathepsin D [122] and chemokine decoy receptor ACKR2/D6 [2,123], which suppresses the anti-cancer effect of these two CC chemokines. The gene discussed is CCL4; the disease is cancer.